Oral Food Challenge: A Primer for the Practitioner

Oral food challenges are a safe, effective, objective and invaluable procedure to definitively diagnose food allergy. This recorded webinar provides a deep dive on how to safely perform these procedures in your office, including setting up a safe environment, selecting candidates, choosing foods & vehicles. Presented by: Jonathon Spergel, David Fleischer and Matthew Greenhawt.

Target Audience
Allergists, allied health and other allergy practitioners.

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material activity for a maximum of 1 AMA PRA Category I Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgement
This activity was supported by an independent educational grant from DBV Technologies.

Target Audience

Allergists, allied health and other allergy practitioners.

Learning Objectives

To provide the practitioner with the tools to

Select appropriate patients for an oral food challenge (OFC)
Set up the office to conduct an OFC
Counsel and consent patients for an OFC
Design a challenge protocol, choose appropriate challenge vehicle and dosing strategy
Manage and treat a reaction
Counsel the patient post-challenge irrespective of the outcome

Additional information Disclosure:

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. The ACCME defines a “commercial interest” as any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

All identified conflicts of interest have been resolved.

Jonathon Spergel, MD, PhD is Professor of Pediatrics at Perelman School of Medicine, University of Pennsylvania

Nothing to disclose

David M Fleischer, MD is Associate Professor Pediatrics-Allergy at University of Colorado School of Medicine

Advisory Board, Consulting Fees; DBV Technologies, INSYS Therapeutics, Aquestive, DOTS Technology Corp. Investigator, Contracted Research: Aimmune, DBV. Speaker, Honorarium: Abbott, Nutricia

Matthew Greenhawt, MD, MBA, MSc is Associate Professor Pediatrics-Allergy at University of Colorado School of Medicine

Advisory Board, Honorarium: Aimmune, Genentech, Sanofi Genzyme, Aquestive, Kaleo, Nutrica, Nestle, DBV Technologies, Allergenis, Intrommune Therapeutics, Prota, Allergy Therapeutics. Speaker, Honorarium: Aimmune, Thermo Fisher, DBV, Before Brands.